Product Reports Resources Pricing Login Book a demo

Centessa Pharmaceuticals

Biotech & Life Sciences · Boston, United States · Founded 2021 · IPO 2021

Merger of ten pharmaceutical companies developing drugs for sleep-wake disorders, neurological conditions and cancer

Valuation $6.11B
Revenue $15M

Investors

14 investors on Centessa Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 14 investors entered at this stage
BVF Partners
Cormorant Asset Management
General Atlantic
Logos Capital
Boxer Capital
Samsara BioCapital
T. Rowe Price
Franklin Templeton Investments
EcoR1 Capital
LifeSci Venture Partners
Janus Henderson Investors
Wellington Management
Venrock
Vida Ventures

Global footprint

Where Centessa Pharmaceuticals has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States88.3%
🇬🇧 United Kingdom9.3%
🇫🇷 France1.3%
🇨🇭 Switzerland1.2%
🇮🇪 Ireland1.1%
5 countries shown
Web traffic by country
12K monthly visits
across markets
🇺🇸 United States65%
🇯🇵 Japan10.8%
🇮🇳 India6.7%
🇵🇭 Philippines5%
🇨🇦 Canada4.2%
Top 5 markets shown

Talent graph

The shape of Centessa Pharmaceuticals's talent

Dealroom maps Centessa Pharmaceuticals's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Centessa Pharmaceuticals's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$62M patent portfolio · 43 active families

Estimated portfolio value
$62M
1.0% of market cap · 4.5× larger than top peer Travere Therapeutics ($14M)
43 active patent families
Where Centessa Pharmaceuticals innovates DiseaseAntigenAntigen Processing CellAntigen processingBenzamide

Where Centessa Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Centessa Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Centessa Pharmaceuticals's 10 investments and acquisitions.

Every disclosed deal where Centessa Pharmaceuticals appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

10 deals across Centessa Pharmaceuticals's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Centessa Pharmaceuticals's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        10 of 10 deals

        Market sentiment

        What the market is saying about Centessa Pharmaceuticals

        An AI-synthesized read of the highest-engagement posts about Centessa Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Centessa Pharmaceuticals on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.